Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclase
- 1 October 1997
- journal article
- research article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 8 (15) , 3189-3196
- https://doi.org/10.1097/00001756-199710200-00002
Abstract
WE have isolated a cDNA encoding the 5-HT4S receptor by RT-PCR on poly (A)+ RNA from both human heart and brain. The sequence homology with the rat and mouse 5-HT4 receptors was high: 93.8% of identity in the amino acid sequence. None of the 24 amino acid substitutions observed between rat and human receptors are at positions likely to modify their pharmacology. Comparing the pharmacological properties of six agonists and five antagonists on rat and human 5-HT4S receptors revealed no significant differences. We have analyzed the behavior of renzapride, a full and a partial agonist on mouse colliculi neurons and human heart biological responses respectively. The coupling efficiency of renzapride was two-fold lower than that of 5-HT for the stimulation of 5-HT4S receptors transfected in two different cell lines (LLC-PK1 and COS-7), but increasing the receptor density suppressed the partial agonist effect of renzapride.Keywords
This publication has 6 references indexed in Scilit:
- Identification of the G Protein-coupled Receptor Kinase Phosphorylation Sites in the Human β2-Adrenergic ReceptorPublished by Elsevier ,1996
- Protein kinases that phosphorylate activated G protein‐coupled receptorsThe FASEB Journal, 1995
- 5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic β-adrenoceptor blockadeNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1994
- G proteins and G-protein-coupled receptors: structure, function and interactionsCurrent Opinion in Neurobiology, 1991
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973